254 related articles for article (PubMed ID: 27993681)
1. Lysophosphatidic acid (LPA) signaling via LPA
Takahashi K; Fukushima K; Onishi Y; Inui K; Node Y; Fukushima N; Honoki K; Tsujiuchi T
Biochem Biophys Res Commun; 2017 Jan; 483(1):652-657. PubMed ID: 27993681
[TBL] [Abstract][Full Text] [Related]
2. Effects of LPA
Takahashi K; Fukushima K; Otagaki S; Ishimoto K; Minami K; Fukushima N; Honoki K; Tsujiuchi T
J Recept Signal Transduct Res; 2018 Feb; 38(1):71-75. PubMed ID: 29369010
[TBL] [Abstract][Full Text] [Related]
3. Diverse effects of LPA4, LPA5 and LPA6 on the activation of tumor progression in pancreatic cancer cells.
Ishii S; Hirane M; Fukushima K; Tomimatsu A; Fukushima N; Tsujiuchi T
Biochem Biophys Res Commun; 2015 May; 461(1):59-64. PubMed ID: 25849892
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid-induced YAP/TAZ activation promotes developmental angiogenesis by repressing Notch ligand Dll4.
Yasuda D; Kobayashi D; Akahoshi N; Ohto-Nakanishi T; Yoshioka K; Takuwa Y; Mizuno S; Takahashi S; Ishii S
J Clin Invest; 2019 Jul; 129(10):4332-4349. PubMed ID: 31335323
[TBL] [Abstract][Full Text] [Related]
5. Induction of lysophosphatidic acid (LPA) receptor-mediated signaling regulates cell motility and survival to anticancer drugs in cancer cells treated with hydrogen peroxide.
Takai M; Takamoto M; Amano Y; Yamamoto M; Hara K; Yashiro N; Tsujiuchi T
Adv Biol Regul; 2023 Aug; 89():100978. PubMed ID: 37603941
[TBL] [Abstract][Full Text] [Related]
6. Different effects of lysophosphatidic acid receptor-2 (LPA
Ishimoto K; Minami A; Minami K; Ueda N; Tsujiuchi T
J Recept Signal Transduct Res; 2021 Feb; 41(1):93-98. PubMed ID: 32672083
[TBL] [Abstract][Full Text] [Related]
7. Effects of lysophosphatidic acid (LPA) signaling via LPA receptors on cellular functions associated with ATP reduction in osteosarcoma cells treated with ethidium bromide.
Kurisu R; Takamoto M; Minami K; Ueda N; Yamada M; Shima N; Otani T; Sakai Y; Kondo D; Tsujiuchi T
J Bioenerg Biomembr; 2022 Apr; 54(2):109-117. PubMed ID: 35260987
[TBL] [Abstract][Full Text] [Related]
8. Diverse effects of LPA receptors on cell motile activities of cancer cells.
Tsujiuchi T; Hirane M; Dong Y; Fukushima N
J Recept Signal Transduct Res; 2014 Jun; 34(3):149-53. PubMed ID: 24460191
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidic acid signaling via LPA
Fukushima K; Takahashi K; Yamasaki E; Onishi Y; Fukushima N; Honoki K; Tsujiuchi T
Exp Cell Res; 2017 Mar; 352(1):139-145. PubMed ID: 28189636
[TBL] [Abstract][Full Text] [Related]
10. Non-Edg family LPA receptors: the cutting edge of LPA research.
Yanagida K; Ishii S
J Biochem; 2011 Sep; 150(3):223-32. PubMed ID: 21746769
[TBL] [Abstract][Full Text] [Related]
11. Effects of bisphenol A and 4-nonylphenol on cellular responses through the different induction of LPA receptors in liver epithelial WB-F344 cells.
Dong Y; Araki M; Hirane M; Tanabe E; Fukushima N; Tsujiuchi T
J Recept Signal Transduct Res; 2014 Jun; 34(3):201-4. PubMed ID: 24460192
[TBL] [Abstract][Full Text] [Related]
12. Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA
Minami K; Ueda N; Maeda H; Ishimoto K; Otagaki S; Tsujiuchi T
Biochem Biophys Res Commun; 2019 Sep; 517(2):359-363. PubMed ID: 31362892
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid receptors LPA4 and LPA6 differentially promote lymphocyte transmigration across high endothelial venules in lymph nodes.
Hata E; Sasaki N; Takeda A; Tohya K; Umemoto E; Akahoshi N; Ishii S; Bando K; Abe T; Kano K; Aoki J; Hayasaka H; Miyasaka M
Int Immunol; 2016 Jun; 28(6):283-92. PubMed ID: 26714589
[TBL] [Abstract][Full Text] [Related]
14. Involvement of LPA receptor-5 in the enhancement of cell motile activity by phorbol ester and anticancer drug treatments in melanoma A375 cells.
Fukushima K; Takahashi K; Kurokawa A; Ishimoto K; Otagaki S; Minami K; Fukushima N; Honoki K; Tsujiuchi T
Biochem Biophys Res Commun; 2018 Jan; 496(1):225-230. PubMed ID: 29309788
[TBL] [Abstract][Full Text] [Related]
15. Role of LPA4/p2y9/GPR23 in negative regulation of cell motility.
Lee Z; Cheng CT; Zhang H; Subler MA; Wu J; Mukherjee A; Windle JJ; Chen CK; Fang X
Mol Biol Cell; 2008 Dec; 19(12):5435-45. PubMed ID: 18843048
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid receptor-5 negatively regulates cellular responses in mouse fibroblast 3T3 cells.
Dong Y; Hirane M; Araki M; Fukushima N; Tsujiuchi T
Biochem Biophys Res Commun; 2014 Apr; 446(2):585-9. PubMed ID: 24632199
[TBL] [Abstract][Full Text] [Related]
17. Negative regulation of cell motile and invasive activities by lysophosphatidic acid receptor-3 in colon cancer HCT116 cells.
Fukui R; Tanabe E; Kitayoshi M; Yoshikawa K; Fukushima N; Tsujiuchi T
Tumour Biol; 2012 Dec; 33(6):1899-905. PubMed ID: 22763559
[TBL] [Abstract][Full Text] [Related]
18. LPA induces osteoblast differentiation through interplay of two receptors: LPA1 and LPA4.
Liu YB; Kharode Y; Bodine PV; Yaworsky PJ; Robinson JA; Billiard J
J Cell Biochem; 2010 Mar; 109(4):794-800. PubMed ID: 20069565
[TBL] [Abstract][Full Text] [Related]
19. Differential expressions and DNA methylation patterns of lysophosphatidic acid receptor genes in human colon cancer cells.
Tsujino M; Fujii M; Okabe K; Mori T; Fukushima N; Tsujiuchi T
Virchows Arch; 2010 Dec; 457(6):669-76. PubMed ID: 20890765
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1.
Shida D; Kitayama J; Yamaguchi H; Okaji Y; Tsuno NH; Watanabe T; Takuwa Y; Nagawa H
Cancer Res; 2003 Apr; 63(7):1706-11. PubMed ID: 12670925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
